Loading clinical trials...
Loading clinical trials...
Meningiomas are the most common primary intracranial tumors. Current treatment relies on surgical resection and radiotherapy, but molecular predictors for recurrence are lacking. This study aims to in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Collaborators
NCT05278208 · High Grade Glioma, Meningioma, and more
NCT06275919 · Meningioma, Malignant
NCT05940493 · Meningioma
NCT02523014 · Intracranial Meningioma, Recurrent Meningioma, and more
NCT06377371 · Meningioma
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions